Literature DB >> 35978692

Novel RXFP1Modulators for Treating Heart Failure.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2022        PMID： 35978692      PMCID： PMC9377327          DOI： 10.1021/acsmedchemlett.2c00321

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  4 in total

Review 1.  Heart Disease and Relaxin: New Actions for an Old Hormone.

Authors:  Teja Devarakonda; Fadi N Salloum
Journal:  Trends Endocrinol Metab       Date:  2018-03-08       Impact factor: 12.015

Review 2.  Ischemic stroke and select adipose-derived and sex hormones: a review.

Authors:  Kristy L Meadows
Journal:  Hormones (Athens)       Date:  2018-06-06       Impact factor: 2.885

Review 3.  Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis.

Authors:  Anita A Pinar; Tara E Scott; Brooke M Huuskes; Felipe E Tapia Cáceres; Barbara K Kemp-Harper; Chrishan S Samuel
Journal:  Pharmacol Ther       Date:  2020-02-22       Impact factor: 12.310

Review 4.  The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.

Authors:  Ting-Yun Chen; Xiaoyun Li; Ching-Hsia Hung; Harinath Bahudhanapati; Jiangning Tan; Daniel J Kass; Yingze Zhang
Journal:  Mol Genet Genomic Med       Date:  2020-02-26       Impact factor: 2.183
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.